Migraine Relief with Botox Injections
Migraine Treatment with Botox in Long Beach, Effective Relief from Chronic Migraines
Effective Migraine Relief with Botox Injections
FDA-Approved Treatment for Chronic Migraine Management
At Novel U Wellness, we offer Botox® migraine treatment — a clinically proven and FDA-approved solution for individuals suffering from chronic migraine headaches. If you experience 15 or more headache days per month, Botox may be the breakthrough therapy you need to reclaim your quality of life.
What Is Botox for Migraine?
Botox (onabotulinumtoxinA) is a neurotoxin-based injection therapy that blocks the release of pain-signaling chemicals in the brain. Approved by the FDA in 2010 for chronic migraine treatment, Botox is now one of the most widely used and trusted therapies in neurology clinics across the U.S.
How it works: Botox is injected into specific muscles of the head and neck to reduce headache frequency and severity by relaxing overactive pain pathways and preventing the activation of migraine triggers.
Who Is a Candidate for Botox Migraine Treatment?
Botox is indicated for adults who:
Have a diagnosis of chronic migraine (15+ headache days per month, with at least 8 being migraine days)
Have not responded well to oral medications or other preventative treatments
Are seeking a non-opioid, long-term migraine solution
Benefits of Botox for Migraine Headaches
FDA-approved for chronic migraine
Reduces monthly migraine days by up to 50% or more (according to the PREEMPT clinical trials)
Non-surgical, minimally invasive procedure
Administered in-office in under 20 minutes
Long-lasting relief (effects typically last 10–12 weeks)
Can be used alongside other preventive treatments (e.g., CGRP inhibitors)
What to Expect During Treatment
Botox is injected into 31 strategic sites across the forehead, temples, neck, and shoulders
The procedure is quick and involves minimal discomfort
Results typically begin within 7–14 days, with full effect in 4 weeks
Treatment is repeated every 12 weeks for ongoing relief
Novel U Treatments
Additional Medical Supporting Data :
OnabotulinumtoxinA (Botox) injection is an FDA-approved, evidence-based preventive treatment for chronic migraine, consistently shown to reduce headache frequency, improve quality of life, and be well tolerated. Its efficacy for episodic migraine is less clear, with limited and inconsistent evidence.
For chronic migraine (≥15 headache days/month), multiple randomized controlled trials and meta-analyses—including the pivotal PREEMPT 1 and 2 studies—demonstrate that onabotulinumtoxinA reduces headache days by approximately 2–3 days per month compared to placebo, with pooled data showing a reduction of 8.4 headache days versus 6.6 for placebo over 24 weeks.Improvements in migraine-related disability and health-related quality of life are also consistently reported. Real-world data confirm these benefits and suggest durability over at least one year.[9] The American Academy of Pain Medicine guideline supports its use via the PREEMPT protocol (155–195 units injected every 12 weeks).
Safety: OnabotulinumtoxinA is generally well tolerated, with most adverse events being mild or moderate (e.g., neck pain, muscle weakness, injection-site pain) and declining with repeated cycles.No serious systemic adverse events have been reported.
For episodic migraine ,However, some recent prospective studies suggest possible efficacy, but these findings are not yet reflected in guideline recommendations or regulatory approvals.
Summary: OnabotulinumtoxinA is a first-line, FDA-approved preventive therapy for chronic migraine, with robust evidence for efficacy and safety. Its use in episodic migraine remains investigational and is not currently guideline-supported.